企業プロフィール
Seagen 株価・ニュース・カタリスト
- ティッカー:
- SGEN
- 取引所:
- NASDAQ
- セクター:
- Antibody Drugs, ADCs
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for SGEN.
企業概要
事業概要
Seagen was a biotechnology company focused on antibody-drug conjugates and oncology before being acquired by Pfizer. Its identity was tied to cancer therapeutics and the broader validation of ADC technology.
所在地とセクター分類
Seagen was headquartered in the United States and listed on NASDAQ before its acquisition. It sat in oncology biotechnology with a strong U.S. commercial and development presence.
ビジネスモデルの特徴
The business depended on oncology product sales, ADC innovation, and the ability to expand the reach of its platform through development and partnership activity. Investors focused on clinical data, label expansion, and the strategic value of its ADC franchise.
バイオ業界での位置付け
Seagen was one of the most important ADC-focused biotech companies of its time. It occupied a high-catalyst position because oncology readouts and platform validation directly influenced the stock.
今後のカタリスト
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。